Table 1

Clinicopathological features and the expressions of arginase-1 & HepPar-1 in all studied tumorous cases (no=100)
No Age Sex Histological diagnosis of the tumor Arginase-1 expression HepPar-1 expression
1 53 M Well differentiated HCC 2+ 2+
2 45 M Well differentiated HCC 1+ 1+
3 48 M Well differentiated HCC 2+ 2+
4 59 F Well differentiated HCC 2+ 2+
5 60 M Well differentiated HCC 1+ 2+
6 49 M Well differentiated HCC 2+ 1+
7 53 F Well differentiated HCC 2+ 1+
8 55 M Well differentiated HCC 2+ 2+
9 48 M Well differentiated HCC 2+ 2+
10 50 F Well differentiated HCC 1+ 1+
11 52 F Well differentiated HCC 2+ 2+
12 49 M Moderately differentiated HCC 0 0
13 59 M Moderately differentiated HCC 2+ 2+
14 62 M Moderately differentiated HCC 1+ 1+
15 59 M Moderately differentiated HCC 1+ 1+
16 52 F Moderately differentiated HCC 2+ 2+
17 55 M Moderately differentiated HCC 1+ 1+
18 56 F Moderately differentiated HCC 2+ 2+
19 61 M Moderately differentiated HCC 1+ 0
20 60 M Moderately differentiated HCC 2+ 1+
21 59 M Moderately differentiated HCC 2+ 1+
22 51 M Moderately differentiated HCC 0 0
23 55 F Moderately differentiated HCC 2+ 2+
24 61 M Moderately differentiated HCC 1+ 1+
25 49 M Moderately differentiated HCC 2+ 2+
26 55 M Moderately differentiated HCC 1+ 0
27 54 M Moderately differentiated HCC 2+ 2+
28 59 F Moderately differentiated HCC 2+ 2+
29 62 M Moderately differentiated HCC 2+ 2+
30 61 M Moderately differentiated HCC 1+ 0
31 50 M Moderately differentiated HCC 1+ 1+
32 48 M Moderately differentiated HCC 2+ 1+
33 52 F Moderately differentiated HCC 2+ 2+
34 60 F Moderately differentiated HCC 1+ 0
35 52 M Moderately differentiated HCC 2+ 2+
36 56 M Moderately differentiated HCC 1+ 1+
37 57 M Moderately differentiated HCC 0 0
38 58 F Moderately differentiated HCC 2+ 2+
39 65 M Moderately differentiated HCC 2+ 2+
40 55 M Moderately differentiated HCC (metastatic to chest wall) 1+ 1+
41 48 M Moderately differentiated HCC (metastatic to adrenal gland) 1+ 0
42 53 M Poorly differentiated HCC 0 0
43 57 F Poorly differentiated HCC 1+ 0
44 62 M Poorly differentiated HCC 0 0
45 65 M Poorly differentiated HCC 1+ 1+
46 50 F Poorly differentiated HCC 1+ 0
47 54 M Poorly differentiated HCC 0 0
48 56 M Poorly differentiated HCC 0 0
49 52 M Poorly differentiated HCC 1+ 1+
50 60 M Poorly differentiated HCC 0 0
51 62 F Metastatic colonic carcinoma 0 0
52 54 M Metastatic colonic carcinoma 0 0
53 50 F Metastatic colonic carcinoma 0 0
54 45 F Metastatic colonic carcinoma 0 0
55 48 M Metastatic colonic carcinoma 0 0
56 50 F Metastatic colonic carcinoma 0 1+
57 57 M Metastatic colonic carcinoma 0 0
58 49 F Metastatic colonic carcinoma 0 0
59 55 F Metastatic colonic carcinoma 0 2+
60 50 M Metastatic colonic carcinoma 0 0
61 52 M Metastatic colonic carcinoma 0 0
62 60 M Metastatic colonic carcinoma 0 0
63 51 M Metastatic colonic carcinoma 0 0
64 55 F Metastatic colonic carcinoma 0 2+
65 50 M Metastatic colonic carcinoma 0 0
66 49 F Metastatic colonic carcinoma 0 0
67 55 F Metastatic colonic carcinoma 0 0
68 51 F Metastatic colonic carcinoma 0 0
69 53 M Metastatic colonic carcinoma 0 0
70 55 M Metastatic colonic carcinoma 0 0
71 50 M Metastatic colonic carcinoma 0 0
72 52 M Metastatic colonic carcinoma 0 0
73 56 F Metastatic colonic carcinoma 0 0
74 46 M Metastatic colonic carcinoma 0 0
75 50 M Metastatic colonic carcinoma 0 0
76 52 M Metastatic gastric carcinoma 0 2+
77 49 F Metastatic gastric carcinoma 0 0
78 55 M Metastatic gastric carcinoma 0 2+
79 56 M Metastatic gastric carcinoma 0 0
80 50 M Metastatic gastric carcinoma 0 1+
81 52 F Metastatic gastric carcinoma 0 0
82 53 M Metastatic renal cell carcinoma 0 0
83 55 F Metastatic renal cell carcinoma 0 0
84 61 M Metastatic pancreatic carcinoma 1+ 0
85 62 M Metastatic pancreatic carcinoma 0 0
86 60 M Metastatic lung carcinoma 0 0
87 62 F Metastatic lung carcinoma 0 0
88 55 M Metastatic gall bladder carcinoma 0 0
89 60 M Cholagiocarcinoma 1+ 0
90 64 M Cholagiocarcinoma 0 1+
91 59 M Cholagiocarcinoma 0 2+
92 64 F Cholagiocarcinoma 0 0
93 62 F Cholagiocarcinoma 0 0
94 58 M Cholagiocarcinoma 0 0
95 62 F Cholagiocarcinoma 0 0
96 60 M Cholagiocarcinoma 0 0
97 59 F Cholagiocarcinoma 0 0
98 65 M Cholagiocarcinoma 0 0
99 62 M Cholagiocarcinoma 0 0
100 60 M Cholagiocarcinoma 0 0

M= male, F= female, HCC= hepatocellular carcinoma, HepPar-1=hepatocyte paraffin antigen-1,(0) =no staining, (1+) =weak staining, (2+) =strong staining.

Radwan and Ahmed

Radwan and Ahmed Diagnostic Pathology 2012 7:149   doi:10.1186/1746-1596-7-149

Open Data